Improved procedure for the high-performance liquid chromatographic determination of monohydroxylated PAH metabolites in urine.
An improved high-performance liquid chromatographic (HPLC) method for the determination of 3-hydroxybenzo(a)pyrene (3-OHBaP) in urine was developed. The sensitivity and reproducibility of the technique was greatly improved by the addition of 1 mg/L ascorbic acid to the methanol eluent of the HPLC system. This procedure also eliminated the peak splitting and band broadening of the 3-OHBaP peak otherwise observed. Furthermore, it corrected the urine matrix effect on the slope of standard curves. In fact, in the absence of ascorbic acid in the HPLC system, slopes of standard curves were steeper when prepared in a methanolic extract of control rat urine (121 L.nmol-1) than in methanol only (86 L.nmol-1). Both these slopes were smaller than that obtained with the modified mobile phase (244 L.nmol-1). The effect of the latter on the shape and intensity of the 1-hydroxypyrene (1-OHP) chromatographic peak was also investigated. Again, slopes were greater when the standards, prepared in a methanolic extract of urine, were chromatographed with ascorbic acid (380 L.nmol-1) than without (157 L.nmol-1). Therefore, it seems that ascorbic acid, like certain substances in urine, may act by masking specific adsorption sites--probably uncapped silanol residues on the LC 18 column that can retain free 3-OHBaP and 1-OHP metabolites.